Terms: = Head and neck cancer AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987 AND Treatment
97 results:
1. Potential targets of diosgenin for the treatment of oral squamous cell carcinoma and their bioinformatics and transcriptional profiling analyses.
Xiao Y; Xu B; Li X; Ding T; Zhao W; Nie X; Mu J; Xiao Z; Wang Q; Ren Q; Zhang E
Steroids; 2024 May; 205():109393. PubMed ID: 38458369
[TBL] [Abstract] [Full Text] [Related]
2. PHF5A promotes esophageal squamous cell carcinoma progression via stabilizing VEGFA.
Chang Z; Jia Y; Gao M; Song L; Zhang W; Zhao R; Yu D; Liu X; Li J; Qin Y
Biol Direct; 2024 Mar; 19(1):19. PubMed ID: 38429756
[TBL] [Abstract] [Full Text] [Related]
3. LIM domain-containing protein Ajuba inhibits chemotherapy-induced apoptosis by negatively regulating p53 stability in colorectal cancer cells.
Xu B; Li Q; Zhang J; Chen F
Mol Oncol; 2023 Aug; 17(8):1678-1691. PubMed ID: 36931700
[TBL] [Abstract] [Full Text] [Related]
4. [A case report of adult primary soft tissue sarcoma of the head and neck].
Liu L; Qiu H; Hui M; Jiang F; Wang D; Lin Y; Yang X; Yao J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Feb; 37(2):146-149. PubMed ID: 36756833
[No Abstract] [Full Text] [Related]
5. Primary head and neck cancer cell cultures are susceptible to proliferation of Epstein-Barr virus infected lymphocytes.
Shao S; Scholtz LU; Gendreizig S; Martínez-Ruiz L; Florido J; Escames G; Schürmann M; Hain C; Hose L; Mentz A; Schmidt P; Wang M; Goon P; Wehmeier M; Brasch F; Kalinowski J; Oppel F; Sudhoff H
BMC Cancer; 2023 Jan; 23(1):47. PubMed ID: 36639629
[TBL] [Abstract] [Full Text] [Related]
6. Nutlin-3 acts as a DNA methyltransferase inhibitor to sensitize esophageal cancer to chemoradiation.
Chang WL; Hsieh CH; Kuo IY; Lin CH; Huang YL; Wang YC
Mol Carcinog; 2023 Feb; 62(2):277-287. PubMed ID: 36342355
[TBL] [Abstract] [Full Text] [Related]
7. Alterations in p53 Influence hTERT, VEGF and MMPs Expression in Oral cancer Patients.
Singh RD; Patel KA; Patel JB; Patel PS
Asian Pac J Cancer Prev; 2022 Sep; 23(9):3141-3149. PubMed ID: 36172677
[TBL] [Abstract] [Full Text] [Related]
8. p53 Pathway Inactivation Drives SMARCB1-deficient p53-wildtype Epithelioid Sarcoma Onset Indicating Therapeutic Vulnerability Through mdm2 Inhibition.
Oppel F; Shao S; Gendreizig S; Zimmerman MW; Schürmann M; Flavian VF; Goon P; Chi SN; Aster JC; Sudhoff H; Look AT
Mol Cancer Ther; 2022 Nov; 21(11):1689-1700. PubMed ID: 36099437
[TBL] [Abstract] [Full Text] [Related]
9. mdm2 analysis in the management of benign lipomas versus atypical lipomatous tumors/well-differentiated liposarcomas: A useful prognostication tool?
Choi KY; Mack L; Caragea M; Monument M; Puloski S; Bouchard-Fortier A
Am J Surg; 2022 Aug; 224(2):747-750. PubMed ID: 35397923
[TBL] [Abstract] [Full Text] [Related]
10. The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma.
Sihag S; Nussenzweig SC; Walch HS; Hsu M; Tan KS; De La Torre S; Janjigian YY; Maron SB; Ku GY; Tang LH; Shah PM; Wu A; Jones DR; Solit DB; Schultz N; Ganesh K; Berger MF; Molena D
Clin Cancer Res; 2022 Jun; 28(12):2669-2678. PubMed ID: 35377946
[TBL] [Abstract] [Full Text] [Related]
11. ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications.
El Jabbour T; Misyura M; Cowzer D; Zimmermann M; Rimkunas V; Marra A; Derakhshan F; Selenica P; Parilla M; Setton JS; Ceyhan-Birsoy O; Kemel Y; Catchings A; Ranganathan M; Ku GY; Janjigian YY; Zinda M; Koehler M; Stadler Z; Shia J; Reis-Filho JS; Mandelker D
J Natl Cancer Inst; 2022 May; 114(5):761-770. PubMed ID: 35078243
[TBL] [Abstract] [Full Text] [Related]
12. An unusual approach for a cervical mass: sternotomy for the treatment of a giant cervico-thoracic lipoma.
Petruzzi G; Trozzi L; Moretto S; De Virgilio A; Melis E; Gallina FT; Pichi B; Campo F; Facciolo F; Pellini R
Acta Biomed; 2022 Jan; 92(6):e2021477. PubMed ID: 35075061
[TBL] [Abstract] [Full Text] [Related]
13. Epstein Barr virus-positive B-cell lymphoma is highly vulnerable to mdm2 inhibitors in vivo.
Zhang X; Zhang R; Ren C; Xu Y; Wu S; Meng C; Pataer A; Song X; Zhang J; Yao Y; He H; Chen H; Ma W; Wang J; Meric-Bernstam F; Champlin RE; Heymach JV; Rooney CM; Swisher SG; Vaporciyan AA; Roth JA; You MJ; Wang M; Fang B
Blood Adv; 2022 Feb; 6(3):891-901. PubMed ID: 34861697
[TBL] [Abstract] [Full Text] [Related]
14. p53 Activation Effect in the Balance of T Regulatory and Effector Cell Subsets in Patients With Thyroid cancer and Autoimmunity.
Arena A; Stigliano A; Belcastro E; Giorda E; Rosado MM; Grossi A; Assenza MR; Moretti F; Fierabracci A
Front Immunol; 2021; 12():728381. PubMed ID: 34539667
[TBL] [Abstract] [Full Text] [Related]
15. Resveratrol Modulation of Apoptosis and Cell Cycle Response to Cisplatin in head and neck cancer Cell Lines.
Bostan M; Mihaila M; Petrica-Matei GG; Radu N; Hainarosie R; Stefanescu CD; Roman V; Diaconu CC
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204834
[TBL] [Abstract] [Full Text] [Related]
16. Clinical utility of the imunohistochemical co-expression of p53 and mdm2 in thyroid follicular lesions.
Martins MB; de Assis Batista F; Marcello MA; Bufalo NE; Peres KC; Morari EC; Soares FA; Vassallo J; Ward LS
Ann Diagn Pathol; 2021 Aug; 53():151766. PubMed ID: 34111705
[TBL] [Abstract] [Full Text] [Related]
17. Genetic variants and risk of thyroid cancer among Iranian patients.
Jamshidi M; Farnoosh G; Mohammadi Pour S; Rafiee F; Saeedi Boroujeni A; Mahmoudian-Sani MR
Horm Mol Biol Clin Investig; 2021 Feb; 42(2):223-234. PubMed ID: 33544997
[TBL] [Abstract] [Full Text] [Related]
18. GATA binding protein 6 (GATA6) is co-amplified with PIK3CA in patients with esophageal adenocarcinoma and is linked to neoadjuvant therapy.
Plum PS; Löser H; Zander T; Essakly A; Bruns CJ; Hillmer AM; Alakus H; Schröder W; Büttner R; Gebauer F; Quaas A
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1031-1040. PubMed ID: 33300112
[TBL] [Abstract] [Full Text] [Related]
19. Focal adhesion kinase (FAK) inhibitor-defactinib suppresses the malignant progression of human esophageal squamous cell carcinoma (ESCC) cells via effective blockade of PI3K/AKT axis and downstream molecular network.
Zhang L; Zhao D; Wang Y; Zhang W; Zhang J; Fan J; Zhan Q; Chen J
Mol Carcinog; 2021 Feb; 60(2):113-124. PubMed ID: 33283357
[TBL] [Abstract] [Full Text] [Related]
20. First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACAN.
Morfouace M; Stevovic A; Vinches M; Golfinopoulos V; Jin DX; Holmes O; Erlich R; Fayette J; Croce S; Ray-Coquard I; Girard N; Blay JY
ESMO Open; 2020 Dec; 5(6):e001075. PubMed ID: 33262201
[TBL] [Abstract] [Full Text] [Related]
[Next]
